Skip to content

Clinical trials

Phase 1/2 Carcinoma, Renal Cell trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Phase: Phase 1/2 Country / region: Spain Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20151
20163
20171
20181
20202
20212
20221
20232
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting6
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
Bristol-Myers Squibb2
Incyte Biosciences International Sàrl2
Eisai Inc.1
Genmab1
Medicenna Therapeutics, Inc.1
Mural Oncology, Inc1
Nektar Therapeutics1
Oncorena AB1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell17
Carcinoma, Non-Small-Cell Lung7
Melanoma7
Neoplasm Metastasis7
Triple Negative Breast Neoplasms6
Colorectal Neoplasms5
Squamous Cell Carcinoma of Head and Neck5
Carcinoma, Transitional Cell4
Ovarian Neoplasms4
Stomach Neoplasms4

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.